Evidence map›Paper›PMID 23148509›Full record

ArticleRadiation research2012

DNA damage enhancement from gold nanoparticles for clinical MV photon beams.

Ross I Berbeco, Houari Korideck, Wilfred Ngwa, Rajiv Kumar, Janki Patel, Srinivas Sridhar, Sarah Johnson, Brendan D Price, Alec Kimmelman, G Mike Makrigiorgos

Abstract read
In one paragraph

Article in Radiation research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Response of HPRT Gene Fragment Functionalized Gold Nanoparticles to Gamma Ray Irradiation.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ross I BerbecoDepartment of Radiation Oncology, Division of Medical Physics and Biophysics, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. rberbeco@lroc.harvard.edu
Houari Korideck
Wilfred Ngwa
Rajiv Kumar
Janki Patel
Srinivas Sridhar
Sarah Johnson
Brendan D Price
Alec Kimmelman
G Mike Makrigiorgos
Brigham and Women's Hospital · USNortheastern University · US

Funding

RADIATION MODULATION OF THE P53 GENER01CA064585 · NCI · DANA-FARBER CANCER INSTITUTE · PI PRICE, BRENDAN D · 1995 to 2016
$4.6M
Functional Analysis of the Tip60 ComplexR01CA093602 · NCI · DANA-FARBER CANCER INSTITUTE · PI PRICE, BRENDAN D · 2002 to 2018
$4.3M
NCI NIH HHS CA93602NCI NIH HHS R01 CA064585NCI NIH HHS R01 CA093602
6 · The paper itself

Abstract

In this study, we quantify the relative damage enhancement due to the presence of gold nanoparticles (GNP) in vitro in a clinical 6 MV beam for various delivery parameters and depths. It is expected that depths and delivery modes that produce a larger proportions of low-energy photons will have a larger effect on the cell samples containing GNP. HeLa cells with and without 50 nm GNP were irradiated at depths of 1.5, 5, 10, 15 and 20 cm. Conventional beams with square aperture sizes 5, 10 and 15 cm at isocenter, and flattening filter free (FFF) beams were used. Relative DNA damage enhancement with GNP was evaluated by γ-H2AX staining. Statistically significant increases in DNA damage with GNP, compared to the absence of GNP, were observed for all depths and delivery modes. Relative to the shallowest depth, damage enhancement was observed to increase as a function of increasing depth for all deliveries. For the conventional (open field) delivery, DNA damage enhancement with GNP was seen to increase as a function of field size. For FFF delivery, a substantial increase in enhancement was found relative to the conventional field delivery. The measured relative DNA damage enhancement validates the theoretically predicted trends as a function of depth and delivery mode for clinical MV photon beams. The results of this study open new possibilities for the clinical development of gold nanoparticle-aided radiation therapy.

Indexed as

DNA DamageMetal NanoparticlesGoldHeLa CellsHumansPhotonsGold

Identifiers

PMID23148509
PMCPMC3525114
OpenAlexW2096024266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.